ArticleDiabetologia2023
The prediabetes conundrum: striking the balance between risk and resources.
Article in Diabetologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Intervening Early in the Cardiovascular-Kidney-Metabolic Syndrome: Expert Recommendations from the United Arab Emirates on the Management of Prediabetes.Vascular health and risk management · 2026Guideline
- [The Effect of Konjac Glucomannan on Blood Glucose and Insulin Levels in Obese Patients With Prediabetes].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026Trial
- A Randomized Controlled Pilot Study of the Food Order Behavioral Intervention in Prediabetes.Nutrients · 2023Trial
- One-hour postload glucose compared to prediabetes criteria as predictive markers of type 2 diabetes in Latin America.Journal of the Endocrine Society · 2026Article
- Effectiveness of Nurse-Led Intervention on Prevention of Type 2 Diabetes among Prediabetic Employees of Steel Plant in Odisha: A Pilot Study.Journal of pharmacy & bioallied sciences · 2026Article
- Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study.Cardiovascular diabetology · 2026Observational
- Prediabetes and Risk of All-Cause and Cause-Specific Mortality: A Prospective Study of 114 062 Adults in Mexico City.The Journal of clinical endocrinology and metabolism · 2025Article
- Neutrophil-lymphocyte ratio is a predictor for all-cause and cardiovascular mortality in individuals with prediabetes in a National study.Endocrine · 2025Article
- Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.Diabetologia · 2025Article
- Article
- Longitudinal clinical and proteomic diabetes signatures in women with a history of gestational diabetes.JCI insight · 2024Article
- Unhealthy plant-based diet is associated with a higher cardiovascular disease risk in patients with prediabetes and diabetes: a large-scale population-based study.BMC medicine · 2024Article
- Modern-Day Management of the Dysglycemic Continuum: An Expert Viewpoint from the Arabian Gulf.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024Review
- Prediabetes increases the risk of major limb and cardiovascular events.Cardiovascular diabetology · 2023Article
- Prevalence of prediabetes in Mexico: a retrospective analysis of nationally representative surveys spanning 2016-2022.Lancet regional health. Americas · 2023Article
- Preferences and Adherence of People with Prediabetes for Disease Management and Treatment: A Systematic Review.Patient preference and adherence · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current definition of prediabetes is controversial and subject to continuous debate. Nonetheless, prediabetes is a risk factor for type 2 diabetes, is highly prevalent and is associated with diabetic complications and mortality. Thereby, it has the potential to become a huge strain on healthcare systems in the future, necessitating action from legislators and healthcare providers. But how do we best reduce its associated burden on health? As a compromise between differing opinions in the literature and among the authors of this article, we suggest stratifying individuals with prediabetes according to estimated risk and only offering individual-level preventive interventions to those at high risk. At the same time, we argue to identify those with prediabetes and already established diabetes-related complications and treat them as we would treat individuals with established type 2 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.